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Abstract
Objective—To compare the amount of shared decision making in breast cancer surgery
interactions when providers do and do not make a treatment recommendation.
Methods—We surveyed breast cancer survivors who were eligible for mastectomy and
lumpectomy. Patients reported whether the provider made a recommendation and the
recommendation given. They completed items about their interaction including discussion of
options, pros, cons, and treatment preference. A total involvement score was calculated with
higher scores indicating more shared decision making.
Results—Most patients (85%) reported that their provider made a recommendation. Patients who
did not receive a recommendation had higher involvement scores compared to those who did
(52% vs. 39.1%, p = 0.004). Type of recommendation was associated with involvement. Patients
given different recommendations had the highest total involvement scores followed by those who
received mastectomy and lumpectomy recommendations (65.5% vs. 42.5% vs. 33.2%,
respectively, p < 0.001).
Conclusion—Providers were less likely to present a balanced view of the options when they
gave a recommendation for surgery. Patients who received a recommendation for lumpectomy had
the lowest involvement score.
Practice implications—Providers need to discuss both mastectomy and lumpectomy and elicit
patients’ goals and treatment preferences regardless of whether or not a recommendation is given.
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1. Introduction
Breast conserving surgery with radiation and mastectomy have equivalent survival rates but
differ cosmetically, and with respect to rates of recurrence, and need for radiation [1,2];
therefore, clinical guidelines emphasize the importance of patient’s preferences in selecting
treatments [3]. For breast cancer surgery decisions and other preference sensitive medical
decisions in which there exists more than one appropriate treatment option, providers need
to involve and engage patients in the decision making process [4,5]. Research has shown
that the surgeon plays a key role in patients’ selection of treatment for breast cancer. Not
only do patients select their surgeons as the single most helpful source of information [6,7],
but also most report that their provider’s opinion has the strongest influence on their final
decision in breast cancer surgery [7–9]. Gurmankin et al. [10] found that provider
recommendations can influence patients’ treatment decisions even when that
recommendation goes against the treatment the patient would have chosen in the absence of
a recommendation and when that recommendation was not the one that maximized health.
Therefore, the specific content of the provider–patient conversation is crucial to the
decision-making process.
The amount and type of information that providers convey to their patients has a direct
impact upon whether or not patients are able to make fully informed treatment decisions. For
breast cancer surgery, patients and providers need to discuss the risks and benefits of both
treatment options, mastectomy and lumpectomy, and consider patients’ goals and treatment
preferences when selecting the best option [11,12]. Patients feel strongly about the
importance of receiving a complete presentation of the range of treatment options [8]. Early
stage breast cancer patients also reported a preference for learning the pros and cons of all
treatment options as a basis for decision making regardless of their preferred decision-
making style [8].
When patients are not presented with the full range of treatment options, patient
involvement in these treatment decisions is often insufficient. Hawley et al. [13] surveyed
1038breast cancer patients and found that patients who reported that their surgeon discussed
only one treatment option were more likely to report having had too little involvement in the
treatment decision. Further, when only one treatment option was discussed (primarily breast
conserving surgery), patients were more likely to report that the decision was made by the
surgeon as opposed to a shared decision [13]. This prior research suggests that discussing
both mastectomy and lumpectomy surgical treatment options play an integral role in breast
cancer patients’ perceptions of their involvement in the treatment decision.
There appears to be a tension for patients between the desire for the provider to make a
recommendation and the desire for shared decision making. The aim of this study was to
compare patient reports of involvement in breast cancer surgery interactions when providers
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made a treatment recommendation and when they did not. Our main hypotheses were that
when providers made a treatment recommendation, patients would report less involvement
in the interaction compared to situations where no recommendation was made and that
patients who received a lumpectomy recommendation would have lower involvement scores
compared to those who received other recommendations.
2. Methods
2.1. Samples and procedures
Adult women, diagnosed with early stage (Stage 1 or 2) breast cancer were identified
through cancer registries at four academic medical centers. All women were diagnosed
within 1–3 years prior to contact. Exclusion criteria included bilateral breast cancer, DCIS,
recurrent breast cancer, receipt of neoadjuvant chemotherapy, and inability to read or speak
English. The criteria were set to ensure that the majority of patients were clinically eligible
for mastectomy and lumpectomy. Treating clinicians were required to approve contact of
patients and were able to exclude any patient that was not eligible for both surgical
procedures.
All eligible patients received a letter signed by their physician, a consent form and the
survey in the mail along with a small incentive (book of stamps). Study staff made reminder
phone calls and sent a reminder mailing to non responders two weeks after the initial
mailing. Participants received a small compensation (book of stamps) for completing the
survey.
2.2. Measures
Although several surveys attempt to measure different aspects of the decision making
process, consensus over how to measure shared decision making or patient involvement
does not exist [14,15]. The key features of shared decision making, as derived from the
model in Charles et al. [16], are the presentation of treatment options, a discussion of the
risks and benefits of each option, and discussion of the patients’ preferences and treatment
goals. We based our involvement items on elements from this shared decision making
framework with the premise that patients who report more of these items would be more
likely to have had shared decision making. For the decision about breast surgery, this would
require discussing both mastectomy and lumpectomy, discussing the advantages and
disadvantages of each option and discussing patients’ goals and treatment preferences. One
potential challenge with this approach is that it relies on patient reports. The reliability of
patient reports for these items was examined in a prior study by comparing patients’ reports
to those of a neutral observer who was present during the visit. Both patient and observer
completed the involvement survey the day of the visit and there were high levels of
agreement (75%) across 178 visits [17]. These results provide confidence in reliance on
patients’ ratings of these involvement items.
Involvement items—Seven items spanned across four categories to measure the
interaction between the patient and providers: (1) discussion of options (e.g., did any of your
doctors discuss mastectomy/lumpectomy and radiation as an option for you?) (yes/no), (2)
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amount of discussion of reasons to have each option (a lot/some/a little/not at all), (3)
amount of discussion of reasons not to have each option (a lot/some/a little/not at all), and
(4) discussion of patients’ treatment preference (yes/no). We assigned each patient 1 point
for discussion of both options, for discussion of the pros of both options (a lot or some), for
discussion of the cons of both options (a lot or some), and for discussion of their
preferences. Points were summed and divided by 4 and multiplied by 100 to generate a total
involvement score (range 0–100%) with higher scores indicating more shared decision
making. The total involvement score had good reliability (Cronbach’s alpha = 0.74) in this
sample. We examined the impact of using a different cutoff (e.g., giving responses of “a
little” one point) and this raised overall scores but did not result in any differences in the
relationships across groups. Given the seriousness of this decision, we felt it important that
more than “a little” discussion of the pros and cons occur, so kept the original cutoff.
Recommendation—Patients reported whether any of their providers made a
recommendation and if so “what type of surgery did the doctor think you should have?”
SURE scale—A brief, 4-item version of the widely used Decisional Conflict Scale [18]
that measures patients’ uncertainty about which treatment to choose and factors contributing
to uncertainty (feeling uninformed, unclear values, and unsupported in decision making).
The SURE scale has been shown to have modest reliability (internal consistency scores of
0.54–0.65) and good construct validity in a sample of English-speaking patients as well as a
sample of French-speaking patients facing treatment decisions [19]. Each item that has a
response of yes gets one point, so scores range from 0 to 4. A score of less than 4 on the
scale indicates decisional conflict.
Patient demographics (including age, race, education, and marital status) and treatment
history were also collected. Provider demographics (including age, years in practice,
professional training) and number of early stage breast cancer patients seen each year were
also collected.
2.3. Analyses
First, we tested for differences in demographics for those who did and did not receive a
recommendation, using t-tests for continuous variables and Chi-square for categorical
variables. Then, we examined the following three hypotheses:
1. When providers make a treatment recommendation, patients will have lower total
involvement scores. We compared total involvement scores for those who had
received a treatment recommendation and those who did not, using a two tailed t-
test.
2. When providers make a recommendation, they tend to advocate for their
recommendation and are less likely to discuss both options or ask for patients’
preferences. We compared the percentage of patients who reported that the provider
discussed both options, discussed the pros and cons of the recommended option,
and asked for patients’ preferences for those patients who received a treatment
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recommendation and those who did not using Fisher’s exact test for binomial
proportions.
3. Patients who received different treatment recommendations from different
providers would have the highest involvement scores followed by those who
received a mastectomy recommendation and those who received a lumpectomy
recommendation. We tested for differences in total involvement scores among
those who received a treatment recommendation, across the types of
recommendations, using a nonparametric ANOVA with planned comparisons. We
also tested for differences in the individual components using Chi square tests.
3. Results
440 patients completed the surgery survey (response rate 58%). Patients were on average
56.9 years old (SD 11.3), most were white (83.2%), and slightly more than half had a
lumpectomy (62%). Table 1 shows the demographics of the sample by those who received a
treatment recommendation and those who did not. None of the demographics, nor the SURE
score, were significantly associated with receiving a treatment recommendation. Most
patients (85%) reported that their provider made a treatment recommendation for surgery.
The recommendations were mainly for lumpectomy and radiation (65%) followed by
mastectomy (27%). Some patients (8%) received different treatment recommendations from
different providers. At the sites, 15 general surgeons or surgical oncologists were female
(53%), on average 44 years old (SD 7.0 years), and white (80%). They had been in practice
an average of 10.1 years (SD 7.0 years) and saw a median of 100 (Q1 15, Q3 200) early
stage breast cancer patients each year.
The mean total involvement score for the sample was 41.3% (SD 35.5). The total
involvement score did not vary by site. Consistent with our first hypothesis, patient total
involvement was higher when the provider did not give a treatment recommendation
compared to when the provider did give a recommendation (52.0% vs. 39.1%, p = 0.004).
We also examined whether or not receiving a treatment recommendation was associated
with the specific aspects of the interaction between the patient and provider. As shown in
Table 2, patients who did not receive a treatment recommendation were more likely to have
heard about both mastectomy and lumpectomy treatment options (73.0% vs. 55.7%, p =
0.006) and were more likely to report that their provider asked about their preferences
(66.2% vs. 45.1%, p < 0.001).
The type of treatment recommendation that a patient received was also associated with
involvement in the treatment decision (F(2, 352) = 9.26, p < 0.001). As predicted, patients
who received different treatment recommendations had the highest total involvement scores
on average (65.5% SD 35.4%) followed by those who received a recommendation for
mastectomy (42.5% SD 35.0%) and lumpectomy (33.2% SD 34.35%). The type of treatment
recommendation received was also associated with the type of interaction between the
patient and her provider (see Table 3). Patients who received different treatment
recommendations from different providers were most likely to have heard about both
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mastectomy and lumpectomy treatment options compared to patients who received a
mastectomy or a lumpectomy recommendation (89.7% vs. 61.9% vs. 47.2%, p < 0.001).
4. Discussion and conclusion
4.1. Discussion
This study examined the association between making treatment recommendations and the
nature of the interaction between patients and providers. A treatment recommendation was
associated with a lower total involvement score and with a different kind of conversation
between the patient and provider. In particular, we found that providers were less likely to
discuss both treatment options or ask for patients’ treatment preferences when they gave a
recommendation.
The specific treatment recommendation was also associated with the patients’ overall
involvement score. As predicted, patients had the highest total involvement scores when
they received different treatment recommendations from different providers. Because
receiving more than one treatment recommendation may allow the patient to obtain a more
balanced and complete set of information about their treatment options, many advocates
urge patients to get a second opinion [20,21]. However, conflicting opinions can also
increase patients’ decisional conflict and delay treatment [22]. As a way to compromise
between these differing perspectives, perhaps the solution is for providers to give a more
balanced discussion of options at the outset of the decision process.
Our analysis found that providers discussed the option to have a lumpectomy much more
often than the option to have a mastectomy. In fact, the lowest involvement score was
among patients who received a lumpectomy recommendation, a finding consistent with
previous literature [12,23]. Collins et al. [12] found that while many patients viewed
lumpectomy with radiation as the preferred treatment for breast cancer, 35% of well-
informed women preferred to have a mastectomy. In another study, Katz et al. [23] found
that greater patient involvement was associated with higher receipt of mastectomy. As is
evident in these studies, the choice to have a mastectomy is often associated with being
well-informed and more involved. These findings are particularly enlightening in our sample
considering that the majority of patients did receive a recommendation for a lumpectomy.
Providers should be aware of how the option to have a mastectomy is being presented,
particularly when they give a lumpectomy recommendation.
Other studies have also documented inconsistencies in the information that patients receive
regarding breast cancer treatment decisions. Siminoff and Fetting [24] found that
oncologists varied considerably in the amount and specificity of information conveyed to
patients regarding the risks and benefits of treatment in adjuvant therapy. In this study of
100 women facing an adjuvant treatment decision, 80% made their decision based on their
provider’s primary treatment recommendation [24]. Clearly, provider recommendations
have a substantial impact on the patients’ final treatment decision. A recent study by Frosch
et al. [25] suggests that patients are reluctant to challenge a providers’ recommendation,
even if they prefer a different option. It may be that there are some unintended negative
consequences of making a treatment recommendation.
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Previous research has shown that patients often place great importance upon their provider’s
recommendation [7–9]. Therefore, it may be impractical to suggest that a provider not share
his/ her opinions or make a treatment recommendation. In fact, a detailed discussion
between the patient and provider, followed by a recommendation that takes into account the
patients’ goals and concerns may result in a high quality decision making process. This
approach reflects the interpretive or deliberative models of decision making [26]. For
example, in the interpretive model, the options and outcomes are discussed as are the
patients’ goals and values, then the physician summarizes with a recommendation (e.g.,
“From what you said, it seems that it is very important for you to keep your breast, and you
are not very concerned about the chance of having a reexcision, so I would recommend
lumpectomy and radiation.”) The timing and content of the recommendation may be more
important than whether or not a recommendation is given. For preference-sensitive
situations, such as breast cancer surgery, the provider might know which options are
possible clinically, but until a discussion of the patient’s goals and concerns has taken place,
the provider cannot make a patient-centered recommendation.
The involvement items used in this study were based on the shared decision making model
by Charles et al. [16]. The involvement score is used as to assess the extent to which there
was a shared decision making process. These are necessary elements, without which a
shared decision making process is unlikely to have occurred. However, they are not
sufficient, as patients with a high involvement score might not have had a shared decision
making process. For instance, the provider may have discussed the options and outcomes “a
lot,” but volume of information may have been overwhelming, and the framing of the
information (e.g., as survival or mortality) may not have been balanced. Further, it might be
satisfactory to have “a little” discussion of pros or cons, and we examined the results with a
revised scoring and found the same significant relationships. The involvement score is not
intended to provide a comprehensive evaluation of the quality of a decision or set of
interactions. That would require assessing patients’ knowledge, the extent to which the
treatment matches patients’ goals, as well as other outcomes [27].
There are several limitations of the study that should be noted. Patients were surveyed on
average 2½ years after the decision, which may have impacted their recall of clinical
conversations with their health care providers. It is unclear in which direction patients’ recall
may be biased; however, patients may selectively recall aspects of discussions with their
provider that reflect the treatment decision that was made. We examined involvement scores
and time since diagnosis in this sample and did not find any trends. The retrospective data
do not allow us to determine causality, i.e., whether lower involvement leads to a
recommendation or vice versa; nor is it able to control for provider-level differences that
may impact the results. Further, there is limited ability to generalize the results to diverse
populations treated outside academic cancer centers or to other breast cancer or preference
sensitive decisions. Future studies are needed to examine the psychometric properties of the
survey instrument in more detail, to study whether there is a causal relationship between
treatment recommendations and involvement, and to explore whether these findings hold
true in other preference sensitive decisions.
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This study found an association between the type of treatment recommendation regarding
breast cancer surgical decisions and the amount of shared decision making in the interaction.
Patients are not getting a balanced view of the options, or being asked their preferences,
particularly when providers recommend a lumpectomy. It appears that providers are not
discussing the option to have a mastectomy or eliciting patients’ treatment preferences often
enough to ensure shared decision making in these interactions.
4.3. Practice implications
Providers need to give an overview of all treatment choices and the benefits and risks of
those options regardless of whether a treatment recommendation is given. Perhaps the
timing and content of the recommendation is more important than whether or not a
recommendation is given.
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Table 1
Demographics of study sample and those who did and did not receive a treatment recommendation.
Characteristic Overall
N = 440 (%)
Treatment
recommendation
N = 366 (%)
No treatment
recommendation
N = 74 (%)
p value
Age, mean (SD) 56.9 (11.3) 57.0 (11.3) 56.5 (11.5) 0.76
Breast cancer stage I (vs. Stage II) 265 (60.2) 218 (59.6) 47 (63.5) 0.53
Education 0.89
  ≥College graduate 279 (63.4) 231 (63.1) 48 (64.9)
  Some college 106 (24.1) 88 (24) 18 (24.3)
  High school or less 55 (12.5) 47 (12.8) 8 (10.8)
Married/committed relationship (vs. single/divorced/widowed) 297 (67.8) 249 (68.4) 48 (64.9) 0.55
Race white (vs. other) 362 (83.2) 313 (86.5) 59 (80.8) 0.21
Hispanic (vs. non Hispanic) 13 (3.0) 11 (3.0) 2 (2.8) 0.91
Income 0.93
  ≤30,000 59 (14.3) 48 (14.1) 11 (15.1)
  30,001–60,000 87 (21.1) 70 (20.6) 17 (23.3)
  60,001–100,000 107 (24.3) 88 (25.9) 19 (26)
  >100,000 160 (38.7) 134 (39.4) 26 (35.6)
SURE scale, mean (SD) 3.56 (1.0) 3.57 (1.04) 3.51 (1.08) 0.66
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Table 2
Reports of involvement for patients who did and did not receive a treatment recommendation.
Involvement item Overall
(N = 440) %
Treatment
recommendation
(N = 366) %
No treatment
recommendation
(N = 74) %
p value
Provider mentioned both mastectomy and lumpectomy as treatment
options
58.6 55.7 73.0 0.006
Provider talked about the pros of both mastectomy and lumpectomy 35.2 33.9 41.9 0.12
Provider talked about the cons of both mastectomy and lumpectomy 22.7 21.9 27.0 0.33
Provider asked for patients’ treatment preference 48.6 45.1 66.2 <0.001
Mean total involvement score 41.3 39.1 52.0 0.004
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